Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL142694 | 0.97 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL20136163 | 0.97 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL23391375 | 0.94 | CYP1A2 (0.33) | CYP1A2 | |
| Phosphine SCHEMBL31470123 | 0.94 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL3720697 | 0.94 | — | — | |
| SCHEMBL15658845 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL2827462 | 0.92 | CYP1A2 (0.32) | CYP1A2 | |
| Iodide SCHEMBL2831150 | 0.92 | CYP1A2 (0.32) | CYP1A2 | |
| Bromide SCHEMBL2829754 | 0.92 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL20136165 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179043-A1 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORP (US) | 2025-06-05 | — | — | US | disclosed |
| US-20250163010-A1 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORP (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250154124-A1 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORP (US) | 2025-05-15 | — | — | US | disclosed |
| CN-118715213-A | Process for preparing N- (1-methylcyclopropyl) -2- (3-pyridinyl) -2H-indazole-4-carboxamide and intermediates thereof | FMC公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118715212-A | Preparation of N- (1-methylcyclopropyl) -2- (3-pyridinyl) -2H-indazole-4-carboxamide and intermediates thereof | FMC公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118679154-A | Preparation of N- (1-methylcyclopropyl) -2- (3-pyridinyl) -2H-indazole-4-carboxamide and intermediates thereof | FMC公司 | 2024-09-20 | — | — | CN | disclosed |
| EP-4121407-B1 | CATALYTIC PROCESS FOR PREPARING AN ALPHA, BETA-ETHYLENICALLY UNSATURATED CARBOXYLIC ACID SALT | BASF SE (DE) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023158770-A1 | THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORPORATION (US) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023158769-A1 | PROCESSES FOR THE PREPARATION OF N-(1- METHYLCYCLOPROPYL)-2-(3 -PYRIDINYL)-2H- INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORPORATION (US) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023158771-A1 | THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | FMC CORPORATION (US) | 2023-08-24 | — | — | WO | disclosed |
| US-20170217869-A1 | PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT | BASF SE (DE) | 2017-08-03 | — | — | US | disclosed |
| US-9670187-B2 | Processes for preparing antiviral compounds | GILEAD PHARMASSET LLC (US) | 2017-06-06 | — | — | US | disclosed |
| US-20170107166-A1 | PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT USING AN ARYLOXIDE | BASF SE (DE) | 2017-04-20 | — | — | US | disclosed |
| EP-3154984-A1 | PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2017-04-19 | — | — | EP | disclosed |
| US-20150361073-A1 | PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2015-12-17 | — | — | US | disclosed |
| WO-2015191437-A1 | PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS | GILEAD PHARMASSET LLC (US) | 2015-12-17 | — | — | WO | disclosed |
| EP-2435184-B1 | PROCESS FOR PREPARING A COMPLEX | JOHNSON MATTHEY PLC (GB) | 2015-02-25 | — | — | EP | disclosed |
| US-8207364-B2 | Process for preparing a complex | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-06-26 | — | — | US | disclosed |
| WO-2010136793-A1 | PROCESS FOR PREPARING A COMPLEX | JOHNSON MATTHEY PLC (GB) | 2010-12-02 | — | — | WO | disclosed |
| US-20100305349-A1 | PROCESS FOR PREPARING A COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170107166-A1 | PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT USING AN ARYLOXIDE | ACOX1, ALOX12, SCO2 | CYP1A2 175/4885 |
| US-20150361073-A1 | PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, SAMHD1 | CYP1A2 1069/4885 |
| US-20250179043-A1 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | ACHE, CYP4B1, CYP3A4 | CYP1A2 12/4885 |
| US-20250154124-A1 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | ACHE, CYP4B1, CYP3A4 | CYP1A2 12/4885 |
| US-20100305349-A1 | PROCESS FOR PREPARING A COMPLEX | EGFR, C9, C1R | CYP1A2 866/4885 |
| US-20170217869-A1 | PROCESS FOR PREPARING AN UNSATURATED CARBOXYLIC ACID SALT | CPN1, CA2, CHRND | CYP1A2 868/4885 |
| US-20250163010-A1 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | ACHE, CYP4B1, CYP3A4 | CYP1A2 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.